Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 2,050 Jul 27 – Oct 24, 2026
- Disclosed funding
- $103.7B 1443 disclosed amounts
- Median round
- $10.3M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| EG Entravel GroupCompany profile Entravel Group provides hotel supply and booking technology that businesses use to offer travel under their own brands. Entravel Group provides hotel supply and booking technology that businesses use to offer travel under their own brands. | $7.5M | Funding roundUndisclosed | Travel tech | Denmark | Investors | |
| Y YunoCompany profile Yuno connects enterprise merchants, banks and wallets to payment providers, local payment methods and fraud tools through a single API. Yuno connects enterprise merchants, banks and wallets to payment providers, local payment methods and fraud tools through a single API. | $45M | Series B | Fintech | Colombia | Investors | |
| BT Beyang TherapeuticsCompany profile AI-driven drug discovery company using its ExCEED molecular design platform AI-driven drug discovery company using its ExCEED molecular design platform | $30M | Series A | Biotech | China | Investors | |
| F FlairMakersCompany profile FlairMakers connects hospitality businesses with freelance professionals for shifts and project work. FlairMakers connects hospitality businesses with freelance professionals for shifts and project work. | £500K | Pre-seed | Business services | United Kingdom | Investors | |
| AH Amplifica Holdings GroupCompany profile Amplifica develops injectable drug candidates intended to reactivate hair follicles in people with androgenetic alopecia. Amplifica develops injectable drug candidates intended to reactivate hair follicles in people with androgenetic alopecia. | $26M | Series B | Biotech | United States | Investors | |
| I InduProCompany profile Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease | $77M | Series B | Biotech | United States | Investors | |
| R RemepyCompany profile Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps | $36M | Series A | Biotech | Israel | Investors | |
| DP Digital Prime TechnologiesCompany profile Provides institutional technology for digital asset and tokenized asset lending Provides institutional technology for digital asset and tokenized asset lending | Undisclosed | StrategicUndisclosed | Fintech | United States | Investors | |
| C ClearJetCompany profile Connects shippers to unused commercial flight cargo space for faster package delivery Connects shippers to unused commercial flight cargo space for faster package delivery | $25M | Growth | Logistics | United States | Investors | |
| Bt Bridge to LifeCompany profile Makes organ preservation and perfusion technology for liver transplants Makes organ preservation and perfusion technology for liver transplants | $110M | Series C+DebtUndisclosed | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 27, 2026
- 1Y Combinator (YC)
Tractian, Blacksmith, Greptile
70rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
46rounds18led - 3Khosla Ventures
Arda Industries, Tolan
33rounds10led - 4Sequoia Capital
Warhound, Whop, Blacksmith
31rounds11led - 5General Catalyst
Tractian, Legora, Different
29rounds11led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →